The 5-lipoxygenase (5-LO) cascade and atherosclerosis in mice and men

被引：0
|
作者：
Loetzer, K [1 ]
Graebner, R [1 ]
Kaiser, B [1 ]
John, N [1 ]
Moos, M [1 ]
Spanbroek, R [1 ]
Hildner, M [1 ]
Funke, H [1 ]
Habenicht, AJR [1 ]
机构：
[1] Univ Jena, Sch Med, Inst Vasc Med, D-07743 Jena, Germany
来源：
CHEMISTRY AND PHYSICS OF LIPIDS | 2004年 / 130卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：21 / 22
页数：2
相关论文
共 50 条
  • [41] 5-Lipoxygenase:: Regulation and possible involvement in atherosclerosis
    Radmark, Olof
    Samuelsson, Bengt
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2007, 83 (03) : 162 - 174
  • [42] STRUCTURE-ACTIVITY-RELATIONSHIPS LEADING TO WY-47,288, A TOPICALLY-ACTIVE INHIBITOR OF 5-LIPOXYGENASE (5-LO) TRANSLOCATION
    KREFT, A
    BICKSLER, J
    PATTISON, T
    BANKER, A
    MUSSER, J
    KEES, K
    YARDLEY, J
    HOLLOWAY, D
    STURM, R
    CHANG, J
    CARLSON, RP
    WONG, A
    HWANG, SM
    MARSHALL, L
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1993, 206 : 40 - MEDI
  • [43] INTERLEUKIN-1 ENHANCES LEUKOTRIENE (LT) SYNTHESIS IN ACTIVATED HUMAN PERIPHERAL-BLOOD MONOCYTES (PBM) AND INCREASES 5-LIPOXYGENASE (5-LO) AND 5-LO ACTIVATING PROTEIN (FLAP) MESSENGER-RNA EXPRESSION
    NASSAR, GM
    MONTERO, A
    BADR, KF
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 760 - 760
  • [44] SYNTHESIS OF SUBSTITUTED-HYDROXYUREIDYL DIARYLTETRAHYDROFURANS, A POTENT CLASS OF DUAL INHIBITORS OF 5-LIPOXYGENASE (5-LO) AND PLATELET-ACTIVATING-FACTOR (PAF)
    CAI, X
    HUSSOIN, S
    KILLIAN, D
    SCANNELL, R
    YAEGER, D
    ECKMAN, J
    HWANG, SB
    LIBERTINEGARAHAN, L
    QIAN, CG
    YEH, G
    IP, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 123 - MEDI
  • [45] A DOUBLE-BLIND MULTICENTER STUDY OF ZILEUTON, A POTENT 5-LIPOXYGENASE (5-LO) INHIBITOR VERSUS PLACEBO IN THE TREATMENT OF SPONTANEOUS ASTHMA IN ADULTS
    ISRAEL, E
    DRAZEN, J
    PEARLMAN, H
    COHN, J
    RUBIN, P
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (01) : 236 - 236
  • [46] IMMUNOSUPPRESSIVE PROPERTIES OF ENISOPROST (ENO) AND A 5-LIPOXYGENASE INHIBITOR (5LO)
    LI, XW
    WEIR, MR
    GOMOLKA, D
    PEPPLER, R
    MORAN, M
    OBRYANLEAR, G
    KIDNEY INTERNATIONAL, 1990, 37 (01) : 421 - 421
  • [47] Trypanosoma cruzi: Effect of the absence of 5-lipoxygenase (5-LO)-derived leukotrienes on levels of cytokines, nitric oxide and iNOS expression in cardiac tissue in the acute phase of infection in mice
    Panis, Carolina
    Mazzuco, Tania Longo
    Fernandes Costa, Caue Zortea
    Victorino, Vanessa Jacob
    Hideko Tatakihara, Vera Lucia
    Yamauchi, Lucy Megumi
    Yamada-Ogatta, Sueli Fumie
    Cecchini, Rubens
    Rizzo, Luiz Vicente
    Pinge-Filho, Phileno
    EXPERIMENTAL PARASITOLOGY, 2011, 127 (01) : 58 - 65
  • [48] THE ROLE OF 5-LIPOXYGENASE (5-LO) PRODUCTS IN MODULATING ALKYL-PAF INDUCED INTRACELLULAR CA2+ FLUXES IN THE HUMAN NEUTROPHIL(PMN)
    PINCKARD, RN
    CASTILLO, R
    DELAPENA, M
    NOVAK, MJ
    FASEB JOURNAL, 1995, 9 (03): : A115 - A115
  • [49] 5-LIPOXYGENASE
    FORDHUTCHINSON, AW
    GRESSER, M
    YOUNG, RN
    ANNUAL REVIEW OF BIOCHEMISTRY, 1994, 63 : 383 - 417
  • [50] A comparison of rat and monkey hepatic cytochrome P450 induction following exposure to 5-lipoxygenase (5-LO) inhibitors in vivo and in vitro.
    Jackson, ER
    Beierschmitt, WP
    Amacher, DE
    FASEB JOURNAL, 2001, 15 (04): : A573 - A573
12345